Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development

Corrine K. Welt, Zachary A. Smith, Donna P Ankerst, Janet E. Hall

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Inhibin B and inhibin A exhibit unique patterns of secretion across the follicular phase of the menstrual cycle. To test the hypothesis that the distinct patterns of inhibin B and inhibin A secretion result from differential regulation by LH and FSH, a series of controlled experiments was designed to dissect the specific effects of LH and FSH at distinct stages of follicle development. After GnRH agonist desensitization, women with small antral follicles were treated with recombinant human LH (rhLH), rhFSH, or rhFSH and estradiol (E2). rhLH or rhFSH was also administered when follicles reached the preovulatory stage in gonadotropin-stimulated or spontaneous cycles. At the small antral stage of development, rhFSH, but not rhLH, administration increased inhibin B (17.4 ± 4.6 to 321.0 ± 97.0 pg/mL; P < 0.05), inhibin A (0.6 ± 0.1 to 2.6 ± 0.6 IU/mL; P < 0.05), and E2 [15.8 ± 3.6 to 95.3 ± 26.9 pg/mL (58.0 ± 13.2 to 349.8 ± 98.7 pmol/L); P < 0.05]. The inhibin B increase preceded inhibin A by 48 h. Addition of E2 to FSH resulted in a greater increase in inhibin B (23.2 ± 6.4 to 865.2 ± 294.5 pg/mL; P < 0.05) than FSH alone (P < 0.05). At the preovulatory stage, rhLH administration increased inhibin A (15.9 ± 10.3 to 21.5 ± 13.7 IU/mL; P < 0.05) and E2 [669.4 ± 285.5 to 943.6 ± 388.1 pg/mL (2457.4 ± 1048.1 to 3464.0 ± 1424.7 pmol/L); P < 0.05], but not inhibin B, as did rhFSH administration in spontaneous cycles [E2:226.4 ± 102.7 to 264.7 ± 121.0 pg/mL (831.1 ± 377.0 to 971.7 ± 444.2 pmol/L); P < 0.05; inhibin A: 2.6 ± 1.3 to 3.7 ± 1.9 IU/mL; P <0.05; and inhibin B: 76.3 ± 32.2 to 77.6 ± 32.8 pg/mL; P = NS]. These findings suggest that increases in both FSH and E2 in the early follicular phase result in increased inhibin B secretion at early stages of follicle development, whereas the selective LH rise in the late follicular phase favors inhibin A secretion from more mature follicles. Thus, both differential secretion of LH and FSH and the stage of follicle development determine the patterns of inhibin A and inhibin B secretion in the normal menstrual cycle.

Original languageEnglish (US)
Pages (from-to)2531-2537
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume86
Issue number6
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Follicle Stimulating Hormone
Luteinizing Hormone
Follicular Phase
inhibin A
inhibin B
Menstrual Cycle
Gonadotropins
Gonadotropin-Releasing Hormone
Estradiol

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. / Welt, Corrine K.; Smith, Zachary A.; Ankerst, Donna P; Hall, Janet E.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 6, 2001, p. 2531-2537.

Research output: Contribution to journalArticle

@article{a5e56660cee94ac6be526df6b3fc8ac3,
title = "Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development",
abstract = "Inhibin B and inhibin A exhibit unique patterns of secretion across the follicular phase of the menstrual cycle. To test the hypothesis that the distinct patterns of inhibin B and inhibin A secretion result from differential regulation by LH and FSH, a series of controlled experiments was designed to dissect the specific effects of LH and FSH at distinct stages of follicle development. After GnRH agonist desensitization, women with small antral follicles were treated with recombinant human LH (rhLH), rhFSH, or rhFSH and estradiol (E2). rhLH or rhFSH was also administered when follicles reached the preovulatory stage in gonadotropin-stimulated or spontaneous cycles. At the small antral stage of development, rhFSH, but not rhLH, administration increased inhibin B (17.4 ± 4.6 to 321.0 ± 97.0 pg/mL; P < 0.05), inhibin A (0.6 ± 0.1 to 2.6 ± 0.6 IU/mL; P < 0.05), and E2 [15.8 ± 3.6 to 95.3 ± 26.9 pg/mL (58.0 ± 13.2 to 349.8 ± 98.7 pmol/L); P < 0.05]. The inhibin B increase preceded inhibin A by 48 h. Addition of E2 to FSH resulted in a greater increase in inhibin B (23.2 ± 6.4 to 865.2 ± 294.5 pg/mL; P < 0.05) than FSH alone (P < 0.05). At the preovulatory stage, rhLH administration increased inhibin A (15.9 ± 10.3 to 21.5 ± 13.7 IU/mL; P < 0.05) and E2 [669.4 ± 285.5 to 943.6 ± 388.1 pg/mL (2457.4 ± 1048.1 to 3464.0 ± 1424.7 pmol/L); P < 0.05], but not inhibin B, as did rhFSH administration in spontaneous cycles [E2:226.4 ± 102.7 to 264.7 ± 121.0 pg/mL (831.1 ± 377.0 to 971.7 ± 444.2 pmol/L); P < 0.05; inhibin A: 2.6 ± 1.3 to 3.7 ± 1.9 IU/mL; P <0.05; and inhibin B: 76.3 ± 32.2 to 77.6 ± 32.8 pg/mL; P = NS]. These findings suggest that increases in both FSH and E2 in the early follicular phase result in increased inhibin B secretion at early stages of follicle development, whereas the selective LH rise in the late follicular phase favors inhibin A secretion from more mature follicles. Thus, both differential secretion of LH and FSH and the stage of follicle development determine the patterns of inhibin A and inhibin B secretion in the normal menstrual cycle.",
author = "Welt, {Corrine K.} and Smith, {Zachary A.} and Ankerst, {Donna P} and Hall, {Janet E.}",
year = "2001",
doi = "10.1210/jc.86.6.2531",
language = "English (US)",
volume = "86",
pages = "2531--2537",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development

AU - Welt, Corrine K.

AU - Smith, Zachary A.

AU - Ankerst, Donna P

AU - Hall, Janet E.

PY - 2001

Y1 - 2001

N2 - Inhibin B and inhibin A exhibit unique patterns of secretion across the follicular phase of the menstrual cycle. To test the hypothesis that the distinct patterns of inhibin B and inhibin A secretion result from differential regulation by LH and FSH, a series of controlled experiments was designed to dissect the specific effects of LH and FSH at distinct stages of follicle development. After GnRH agonist desensitization, women with small antral follicles were treated with recombinant human LH (rhLH), rhFSH, or rhFSH and estradiol (E2). rhLH or rhFSH was also administered when follicles reached the preovulatory stage in gonadotropin-stimulated or spontaneous cycles. At the small antral stage of development, rhFSH, but not rhLH, administration increased inhibin B (17.4 ± 4.6 to 321.0 ± 97.0 pg/mL; P < 0.05), inhibin A (0.6 ± 0.1 to 2.6 ± 0.6 IU/mL; P < 0.05), and E2 [15.8 ± 3.6 to 95.3 ± 26.9 pg/mL (58.0 ± 13.2 to 349.8 ± 98.7 pmol/L); P < 0.05]. The inhibin B increase preceded inhibin A by 48 h. Addition of E2 to FSH resulted in a greater increase in inhibin B (23.2 ± 6.4 to 865.2 ± 294.5 pg/mL; P < 0.05) than FSH alone (P < 0.05). At the preovulatory stage, rhLH administration increased inhibin A (15.9 ± 10.3 to 21.5 ± 13.7 IU/mL; P < 0.05) and E2 [669.4 ± 285.5 to 943.6 ± 388.1 pg/mL (2457.4 ± 1048.1 to 3464.0 ± 1424.7 pmol/L); P < 0.05], but not inhibin B, as did rhFSH administration in spontaneous cycles [E2:226.4 ± 102.7 to 264.7 ± 121.0 pg/mL (831.1 ± 377.0 to 971.7 ± 444.2 pmol/L); P < 0.05; inhibin A: 2.6 ± 1.3 to 3.7 ± 1.9 IU/mL; P <0.05; and inhibin B: 76.3 ± 32.2 to 77.6 ± 32.8 pg/mL; P = NS]. These findings suggest that increases in both FSH and E2 in the early follicular phase result in increased inhibin B secretion at early stages of follicle development, whereas the selective LH rise in the late follicular phase favors inhibin A secretion from more mature follicles. Thus, both differential secretion of LH and FSH and the stage of follicle development determine the patterns of inhibin A and inhibin B secretion in the normal menstrual cycle.

AB - Inhibin B and inhibin A exhibit unique patterns of secretion across the follicular phase of the menstrual cycle. To test the hypothesis that the distinct patterns of inhibin B and inhibin A secretion result from differential regulation by LH and FSH, a series of controlled experiments was designed to dissect the specific effects of LH and FSH at distinct stages of follicle development. After GnRH agonist desensitization, women with small antral follicles were treated with recombinant human LH (rhLH), rhFSH, or rhFSH and estradiol (E2). rhLH or rhFSH was also administered when follicles reached the preovulatory stage in gonadotropin-stimulated or spontaneous cycles. At the small antral stage of development, rhFSH, but not rhLH, administration increased inhibin B (17.4 ± 4.6 to 321.0 ± 97.0 pg/mL; P < 0.05), inhibin A (0.6 ± 0.1 to 2.6 ± 0.6 IU/mL; P < 0.05), and E2 [15.8 ± 3.6 to 95.3 ± 26.9 pg/mL (58.0 ± 13.2 to 349.8 ± 98.7 pmol/L); P < 0.05]. The inhibin B increase preceded inhibin A by 48 h. Addition of E2 to FSH resulted in a greater increase in inhibin B (23.2 ± 6.4 to 865.2 ± 294.5 pg/mL; P < 0.05) than FSH alone (P < 0.05). At the preovulatory stage, rhLH administration increased inhibin A (15.9 ± 10.3 to 21.5 ± 13.7 IU/mL; P < 0.05) and E2 [669.4 ± 285.5 to 943.6 ± 388.1 pg/mL (2457.4 ± 1048.1 to 3464.0 ± 1424.7 pmol/L); P < 0.05], but not inhibin B, as did rhFSH administration in spontaneous cycles [E2:226.4 ± 102.7 to 264.7 ± 121.0 pg/mL (831.1 ± 377.0 to 971.7 ± 444.2 pmol/L); P < 0.05; inhibin A: 2.6 ± 1.3 to 3.7 ± 1.9 IU/mL; P <0.05; and inhibin B: 76.3 ± 32.2 to 77.6 ± 32.8 pg/mL; P = NS]. These findings suggest that increases in both FSH and E2 in the early follicular phase result in increased inhibin B secretion at early stages of follicle development, whereas the selective LH rise in the late follicular phase favors inhibin A secretion from more mature follicles. Thus, both differential secretion of LH and FSH and the stage of follicle development determine the patterns of inhibin A and inhibin B secretion in the normal menstrual cycle.

UR - http://www.scopus.com/inward/record.url?scp=0034977444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034977444&partnerID=8YFLogxK

U2 - 10.1210/jc.86.6.2531

DO - 10.1210/jc.86.6.2531

M3 - Article

C2 - 11397851

AN - SCOPUS:0034977444

VL - 86

SP - 2531

EP - 2537

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -